{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:40:19Z","timestamp":1678560019431},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1983,12,1]],"date-time":"1983-12-01T00:00:00Z","timestamp":439084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1983,12,1]],"date-time":"1983-12-01T00:00:00Z","timestamp":439084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1983,12]]},"DOI":"10.1007\/bf00177415","type":"journal-article","created":{"date-parts":[[2004,8,21]],"date-time":"2004-08-21T12:41:41Z","timestamp":1093092101000},"page":"315-319","source":"Crossref","is-referenced-by-count":1,"title":["Phase II evaluation of rubidazone (NSC-164011) in advanced carcinoma of the breast"],"prefix":"10.1007","volume":"1","author":[{"given":"Frank E.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazil","family":"Gad-el-Mawla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bill","family":"Tranum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence H.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank J.","family":"Panettiere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Athens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Foulkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00177415_CR1","first-page":"301","volume":"274","author":"R Maral","year":"1972","unstructured":"Maral R, Ponsinet G, Jolles G: \u00c9tude de l'activit\u00e9 antitumorale exp\u00e9rimentale d'un nouvel antibiotique semisynth\u00e9tique: La rubidazone (22050 R.P.) CR Hebd Seances Acad Sci Ser D Sci Nat 274:301\u2013304, 1972","journal-title":"Acad Sci Ser D Sci Nat"},{"key":"BF00177415_CR2","volume-title":"Data presented at the Anthracyclines Antibiotic Meeting","author":"C Jacquillat","year":"July 15, 1974","unstructured":"Jacquillat C: Data presented at the Anthracyclines Antibiotic Meeting. NCI Division of Cancer Treatment. Bethesda, Maryland, July 15, 1974"},{"key":"BF00177415_CR3","first-page":"319","volume":"6","author":"DC Tormey","year":"1975","unstructured":"Tormey DC: Adriamycin (NSC-123127) in breast cancer: an overview of studies. Cancer Chemother Rep 6:319\u2013327, 1975","journal-title":"Cancer Chemother Rep"},{"key":"BF00177415_CR4","first-page":"329","volume":"6","author":"B Hoogstraten","year":"1975","unstructured":"Hoogstraten B: Adriamycin (NSC-123127) in the treatment of advanced breast cancer: studies by the Southwest Oncology Group. Cancer Chemother Rep 6:329\u2013338, 1975","journal-title":"Cancer Chemother Rep"},{"key":"BF00177415_CR5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/1097-0142(197607)38:1<13::AID-CNCR2820380104>3.0.CO;2-5","volume":"38","author":"B Hoogstraten","year":"1976","unstructured":"Hoogstraten B, George SL, Samal B, Rivkin SE, Costanzi JJ, Bonnet JD, Thigpen T, Braine H: Combination chemotherapy and adriamycin in patients with advanced breast carcinoma. Cancer 38:13\u201320, 1976","journal-title":"Cancer"},{"issue":"1","key":"BF00177415_CR6","first-page":"135","volume":"65","author":"SS Legha","year":"January 1979","unstructured":"Legha SS, Benjamin RS, Buzdar AU, Hortobagyi GN, Blumenschien GR: Rubidazone in metastatic breast cancer. Cancer Treat Rep 65(1):135\u2013136, January 1979","journal-title":"Cancer Treat Rep"},{"issue":"1","key":"BF00177415_CR7","first-page":"19","volume":"65","author":"J Chauvergne","year":"1978","unstructured":"Chauvergne J, Cappelaere P, Carton M, Gary-Bobo J, Klein T: Rubidazone in metastatic breast cancer. Bull Cancer (Paris) 65(1):19\u201324, 1978","journal-title":"Bull Cancer (Paris)"},{"issue":"7","key":"BF00177415_CR8","first-page":"1053","volume":"62","author":"T Skovsgaard","year":"July 1978","unstructured":"Skovsgaard T, Hansen HH, Mouridsen HT, Nissen NI, Tedersen-Bjergaard J: Clinical trial of ribidazone in solid tumors and malignant lymphomas. Cancer Treat Rep 62(7):1053\u20131058, July 1978","journal-title":"Cancer Treat Rep"},{"key":"BF00177415_CR9","first-page":"1701","volume":"63","author":"JN Ingle","year":"1979","unstructured":"Ingle JN, Ahmann DL, O'Fallon JR, Bisel HF, Kvols LK, Givliani ER: Randomized Phase II trial of rubidazone and adriamycin in women with advanced breast cancer. Cancer Treat Rep 63:1701\u20131705, 1979","journal-title":"Cancer Treat Rep"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00177415.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00177415\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00177415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00177415.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:25:33Z","timestamp":1678559133000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00177415"}},"subtitle":["A Southwest Oncology Group study"],"short-title":[],"issued":{"date-parts":[[1983,12]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1983,12]]}},"alternative-id":["BF00177415"],"URL":"https:\/\/doi.org\/10.1007\/bf00177415","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,12]]}}}